Role of Inhaled Nitric Oxide in Adult Heart or Lung Transplant Recipients

Author:

Rea Rhonda S1,Ansani Nicole T2,Seybert Amy L3

Affiliation:

1. Rhonda S Rea PharmD, Critical Care Specialist, Medical Intensive Care Unit, University of Pittsburgh Medical Center; Assistant Professor of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA

2. Nicole T Ansani PharmD, at time of writing, Associate Director of Drug Information, University of Pittsburgh Medical Center, and Assistant Professor of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh; now, Clinical Education Consultant, Pfizer, Inc., and Adjunct Assistant Professor, School of Pharmacy, University of Pittsburgh

3. Amy L Seybert PharmD, Cardiology Specialist, Coronary Care Intensive Care Unit, University of Pittsburgh Medical Center; Pharmaceutical Care Coordinator, Critical Care Pharmacy; Assistant Professor of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh

Abstract

OBJECTIVE: To evaluate the role of inhaled nitric oxide (iNO) in adult heart or lung transplant recipients. DATA SOURCES: Pertinent literature was identified via a MEDLINE search (1966–July 2004). DATA SYNTHESIS: Pulmonary hypertension leading to right ventricular failure and ischemic reperfusion injury are complications following heart or lung transplant, respectively. A study of 16 heart transplant patients showed improvement in hemodynamic parameters and preservation of right ventricular function, but no improvement in mortality using iNO. Studies of lung transplant patients showed no benefit of iNO on mechanical ventilation duration, hospital length of stay, or mortality, but some studies indicate an improvement in hemodynamic parameters. CONCLUSIONS: iNO shows hemodynamic benefits in early postoperative heart transplant patients with preexisting pulmonary hypertension, and variable hemodynamic benefits in lung transplant recipients. Currently, morbidity and mortality data are not favorable for either indication; use of iNO is supportive and requires further study.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3